Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer

PURPOSE: Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have not been assessed. This study reports testing rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Martin E., Price, Kristin S., Lanman, Richard B., Nagy, Rebecca J., Shah, Irfan, Mathura, Shivam, Mulcahy, Michael, Norden, Andrew D., Goldberg, Stuart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448804/
https://www.ncbi.nlm.nih.gov/pubmed/32923867
http://dx.doi.org/10.1200/PO.19.00274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448804/
https://www.ncbi.nlm.nih.gov/pubmed/32923867
http://dx.doi.org/10.1200/PO.19.00274

Ejemplares similares